The ELECtrode configuraTION CRT Study (ELECTION)
Cardiac resynchronization therapy (CRT) is an accepted treatment for selected heart failure patients. This therapy is delivered using a device (pacemaker (PM) +/- defibrillator (ICD) ) and leads placed in the right atrium (RA), right ventricle (RV) and left ventricle (LV). Rates of LV lead implantation failure and post operative lead related have decreased dramatically over the years, however, the incidence of lead dislodgement and phrenic nerve stimulation is still high. This study is a prospective evaluation of the benefits of having various pace/sense electrode configurations available in a CRT system.
Study Type
OBSERVATIONAL
Enrollment
260
market approved CRT device
to test and compare all available LV pacing and sensing configurations
Time frame: 6 months
to track all programming changes made to the LV pacing/sensing configurations
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.